Aurealis Pharma's Series A Round

Aurealis Pharma raised a round of funding on August 29, 2017.

Aurealis Pharma is a biopharmaceutical company focusing on developing broadly applicable proprietary technology to re-educate the distorted host immune microenvironment in chronic inflammation and can…

Articles about Aurealis Pharma's Series A Round: